Prevention and treatment of peripheral neuropathy
US5633228A · kind A · utility
40Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 29, 1994 |
| Grant date | May 27, 1997 |
| Priority date | — |
| Expiry date | Dec 29, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.